RFA-CA-23-041: Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants of up to $1.8 million to small businesses. Applications closed on December 5, 2023.
From the official notice on Grants.gov, last changed October 4, 2023. Checked November 7, 2026.
- Award ceiling$1.8 million
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeU24
- Clinical trialsNot allowed
- Funded byNCI
- Median yearly award$5.6 million
- Typical project length11 years
- U24, Resource-Related Research Project Cooperative Agreement. Shared research resources such as data centers or coordinating centers, with substantial NIH involvement. Other open U24 notices.
Projects funded under RFA-CA-23-041 were run by National Cancer Institute (NCI, 1 project). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-CA-23-041 in the NIH Guide.
Key dates
| Posted | October 3, 2023 |
|---|---|
| Deadline | December 5, 2023 |
| Archived by Grants.gov | January 10, 2024 |
Who can apply
This opportunity was open to small businesses.
- Small businesses
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See full Notice of Funding Opportunity for additional details on eligibility.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $5.6 million; it allows up to $1.8 million per award.
- Most of the money in the 5 programs behind this notice (61% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate sharing of complex single-cell level data with the cancer research community. The Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC) will serve the dual role of network and data coordination. Administratively the HTAN-DCC will be responsible for meeting coordination, including planning and administration of monthly HTAN Steering Committee meetings, monthly HTAN working group meetings, and semi-annual HTAN face-to-face meetings. A focus on HTAN data and tool reusability through the development and deployment of community education resources will outweigh the need for creating additional data sharing infrastructure in the renewal period. Additionally, it is expected that the HTAN-DCC will remain a testbed for important interactions with the NCI Cancer Research Data Commons (CRDC) and will further drive development of CRDC resources required for sharing, interacting with, and integrating across highly multiplexed imaging datasets. The HTAN-DCC will also work closely with the CRDC to ensure all relevant data and metadata is transferred to the CRDC for long-term data sustainability. Just as they did in the first phase of HTAN, these important interactions will benefit a wide scientific community and have the potential to synergize with other NCI and NIH supported programs. A reduced budget request for the HTAN-DCC reflects reuse of infrastructure developed within the first phase of HTAN, while acknowledging that a significant number of nimble and responsive HTAN-DCC personnel are required for data wrangling, ingest, and sharing.
Funded under RFA-CA-23-041 so far
NIH funded 1 project under RFA-CA-23-041 in fiscal 2024 to 2025, at 1 institution. The median yearly award was $5.6 million.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Human Tumor Atlas Network: Data Coordinating Center | Dana-Farber Cancer Inst | 2025 | $8.9 million |
Who has won Cancer Treatment Research grants before
From fiscal 2021 to 2025, Cancer Treatment Research (93.395) awarded $5.6 billion across 3,622 grant awards, an average of $1.5 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Univeristy of Texas M.D. Anderson Cancer Center | Texas | 144 | $188 million |
| Dana-Farber Cancer Institute, Inc. | Massachusetts | 68 | $185 million |
| Icahn School of Medicine at Mount Sinai | New York | 35 | $179 million |
| Public Health Institute | California | 4 | $168 million |
| Fred Hutchinson Cancer Center | Washington | 57 | $156 million |
Who has won Cancer Biology Research grants before
From fiscal 2021 to 2025, Cancer Biology Research (93.396) awarded $4.3 billion across 3,142 grant awards, an average of $1.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Trustees of Columbia University in the City of New York | New York | 70 | $151 million |
| The Univeristy of Texas M.D. Anderson Cancer Center | Texas | 109 | $144 million |
| Sloan-Kettering Institute for Cancer Research | New York | 66 | $136 million |
| Dana-Farber Cancer Institute, Inc. | Massachusetts | 47 | $107 million |
| The Regents of the University of California, San Francisco | California | 64 | $95.5 million |
Who has won Cancer Cause and Prevention Research grants before
From fiscal 2021 to 2025, Cancer Cause and Prevention Research (93.393) awarded $3.6 billion across 2,517 grant awards, an average of $1.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Univeristy of Texas M.D. Anderson Cancer Center | Texas | 81 | $107 million |
| Sloan-Kettering Institute for Cancer Research | New York | 65 | $99.1 million |
| The Trustees of Columbia University in the City of New York | New York | 48 | $85.3 million |
| Dana-Farber Cancer Institute, Inc. | Massachusetts | 51 | $83.1 million |
| University of North Carolina at Chapel Hill | North Carolina | 49 | $76.1 million |
Other programs behind this notice
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-CA-23-041 still open?
No. It closed on December 5, 2023.
Who can apply for Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed)?
Closed December 5, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.8 million each.
Who has been funded under RFA-CA-23-041?
NIH RePORTER lists 1 project funded under RFA-CA-23-041 in fiscal 2024 to 2025, at 1 institution.
Who has won Cancer Cause and Prevention Research grants before?
The largest recipients over five fiscal years were The Univeristy of Texas M.D. Anderson Cancer Center, Sloan-Kettering Institute for Cancer Research, The Trustees of Columbia University in the City of New York. The program made 2,517 awards worth $3.6 billion in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Microplastics Research and Resource Coordination Center (U24 - Clinical Trial Not Allowed)
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
- Network of the National Library of Medicine Training Center (U24 Clinical Trial Not Allowed)
- Network of the National Library of Medicine Coordinating Center (U24 Clinical Trial Optional)